HBAN London Syndicate
1st June 2018
HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment, and a joint initiative of Enterprise Ireland and InterTradeIreland, has announced that its new London Syndicate plans to invest €3 million in Irish start-ups over the next three years.
Earlier this year, HBAN partnered with the New York-based Digital Irish Angels (DIA) Syndicate, making the London Syndicate the second of HBAN’s international business angel groups. The syndicate has been established to support the creation of a sustainable and driven international network with an affinity to Ireland. HBAN will supply high-potential, investor-ready early-stage and scaling companies to the network.
Over the next 12 months, the syndicate aims to invest in up to six Irish companies that have ambitions to expand into export markets, including the UK. The investors will not only provide these businesses with financial support, but also access to contacts which will enable them to grow. At the inaugural meeting, the syndicate heard pitches from three high potential companies, with one receiving funding within two weeks and another actively closing their funding round.
More than 10 investors have already signed up to the UK-based syndicate, which is being led by experienced entrepreneur and angel investor Harry McDermott. The members come from a wide variety of backgrounds including finance, technology, telecoms, medtech and fintech, and have significant experience investing in start-up companies.
John Phelan, National Director, HBAN, said: “Nearly a third (29%) of all deals done last year were in the booming area of healthcare, medtech and life-sciences, with an average deal value of €510,000, more than double that of the average ICT deal at €227,000. The overall average deal value across all sectors last year was a record high of €285,000, showing the calibre of businesses and the potential for investors.
“We’ve noticed many positive trends in the medtech sector. For example, more than half of the companies that received investment from HBAN’s MedTech Syndicate were led by female entrepreneurs, more than in any other syndicate. Among the successful medtech companies to receive funding last year are AventaMed, OncoMark, ProVerum Medical, Sigmoid Pharma, Incereb and Kite Medical.
“Innovative, ambitious and exciting early-stage companies continue to approach HBAN and we’re committed to growing our roster of suitable angel investors both in Ireland and internationally.”
If you are interested in joining this or any of HBAN’s other syndicates please email info@hban.org for more information.
